CDTX
Venrock Healthcare Capital Partners Iii Lp Reports 9.99% Passive Stake in Cidara Therapeutics Inc as of November 26 - SEC Filing
时间：2024-12-05 05:20:36 市场： 美股 综合
Cidara Therapeutics Announces $105 Million Private Placement
时间：2024-11-21 21:30:43 市场： 美股 综合
Cidara Therapeutics Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $33
时间：2024-11-08 20:22:39 市场： 综合 美股
Cidara Therapeutics Strengthens Its Scientific Advisory Board With Infectious Disease Experts
时间：2024-09-19 20:00:03 市场： 美股 综合
Cidara Therapeutics to Cut 30% Workforce; Shares Down After-Hours Cidara Therapeutics (CDTX) said late Thursday it is cutting 30% of its workforce to substantially reduce capital needs and to focus on the development of CD388, its drug candidate for influenza A and B.The company said that business development discussions continue for its oncology programs, including CBO421.Cidara shares were about 4% lower in after-hours activity following a brief trading halt.Price: 10.90, Change: -0.45, Percent Change: -3.96
时间：2024-09-13 04:51:21 市场： 美股 综合
Cidara Therapeutics Inc: Expects to Initiate Phase 2B Clinical Trial of Cd388 for Prevention of Influenza in Q3 2024
时间：2024-09-13 04:20:47 市场： 美股 综合
Cidara Therapeutics- Estimates Will Incur Charges of About $1.2 Mln for Severance Payments and Employee Benefits, Primarily in Q4 2024
时间：2024-09-13 04:20:47 市场： 美股 综合
Cidara Therapeutics: Reduction in Workforce to Focus on Clinical Development of Cd388
时间：2024-09-13 04:05:13 市场： 美股 综合
Cidara Therapeutics Inc: Continues Business Development Discussions for Its Oncology Dfc Programs
时间：2024-09-13 04:05:13 市场： 美股 综合